Patents-Review.com
🔗 Permalink
Assignee profile:

Enveric Biosciences Canada Inc.

City:

Calgary

Country:

Canada

Published Applications:

25

Last publication date:

2025-09-18

Patent Grants:

25

Last grant date:

2026-03-17

Top Inventors for applications by Enveric Biosciences Canada Inc.

These are the the leading inventors for applications assigned to Enveric Biosciences Canada Inc.:

Recent patent applications by Enveric Biosciences Canada Inc.

Enveric Biosciences Canada Inc. based in Calgary, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-09-18 ✅ Patent 12,577,232 granted on 2026-03-17
US20250289805A1
Chemistry; metallurgy

N-HETEROCYCLE SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING

 #2 | 2025-06-24 ✅ Patent 12,338,231 granted on 2025-06-24
US18752072
Chemistry; metallurgy

N-heterocycle substituted tryptamine derivatives and methods of using

 #3 | 2025-01-14 ✅ Patent 12,195,439 granted on 2025-01-14
US18494382
Chemistry; metallurgy

C1-substituted isopropylamine fused heterocyclic mescaline derivatives

 #4 | 2024-09-12 ✅ Patent 12,138,276 granted on 2024-11-12
US20240299427A1
Human necessities

Halogenated psilocybin derivatives and methods of using

 #5 | 2024-07-25 ✅ Patent 12,492,179 granted on 2025-12-09
US20240246924A1
Chemistry; metallurgy

SUBSTITUTED ETHYLAMINE FUSED HETEROCYCLIC MESCALINE DERIVATIVES

 #6 | 2024-06-20 ✅ Patent 12,358,885 granted on 2025-07-15
US20240199568A1
Chemistry; metallurgy

SUBSTITUTED N-PROPYLAMINE FUSED HETEROCYCLIC MESCALINE DERIVATIVES

 #7 | 2024-05-30 ✅ Patent 12,133,856 granted on 2024-11-05
US20240173340A1
Human necessities

Multi-substituent psilocybin derivatives and methods of using

 #8 | 2024-04-18 ✅ Patent 12,128,058 granted on 2024-10-29
US20240122950A1
Human necessities

Multi-substituent psilocybin derivatives and methods of using

 #9 | 2024-04-11 ✅ Patent 12,428,408 granted on 2025-09-30
US20240116907A1
Chemistry; metallurgy

FUSED HETEROCYCLIC MESCALINE DERIVATIVES

 #10 | 2024-04-11 ✅ Patent 12,378,195 granted on 2025-08-05
US20240116866A1
Chemistry; metallurgy

AMINATED PSILOCYBIN DERIVATIVES AND METHODS OF USING

 #11 | 2023-12-14 ✅ Patent 12,605,361 granted on 2026-04-21
US20230398097A1
Human necessities

CARBOXYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING

 #12 | 2023-11-09 ✅ Patent 12,065,404 granted on 2024-08-20
US20230357185A1
Chemistry; metallurgy

C4-carboxylic acid-substituted tryptamine derivatives and methods of using

 #13 | 2023-11-09 ✅ Patent 12,077,498 granted on 2024-09-03
US20230357145A1
Chemistry; metallurgy

C4-carboxylic acid-substituted tryptamine derivatives and methods of using

 #14 | 2023-10-12 ✅ Patent 11,945,778 granted on 2024-04-02
US20230321040A1
Human necessities

C-carbonothioate-substituted tryptamine derivatives and methods of using

 #15 | 2023-09-21 ✅ Patent 11,746,087 granted on 2023-09-05
US20230295084A1
Chemistry; metallurgy

C4-carboxylic acid-substituted tryptamine derivatives and methods of using

 #16 | 2023-09-21 ✅ Patent 11,998,557 granted on 2024-06-04
US20230293558A1
Human necessities

Halogenated psilocybin derivatives and methods of using

 #17 | 2023-08-31 ✅ Patent 11,918,594 granted on 2024-03-05
US20230270768A1
Human necessities

Multi-substituent psilocybin derivatives and methods of using

 #18 | 2023-07-25 ✅ Patent 11,707,447 granted on 2023-07-25
US17893122
Human necessities

C4-carbonothioate-substituted tryptamine derivatives and methods of using

 #19 | 2023-07-13 ✅ Patent 11,891,359 granted on 2024-02-06
US20230219888A1
Chemistry; metallurgy

Prenylated psilocybin derivatives and methods of using

 #20 | 2023-05-04 ✅ Patent 11,858,895 granted on 2024-01-02
US20230135143A1
Chemistry; metallurgy

Aminated psilocybin derivatives and methods of using

 #21 | 2023-03-23 ✅ Patent 11,891,360 granted on 2024-02-06
US20230086396A1
Chemistry; metallurgy

Glycosylated psilocybin derivatives and methods of using

 #22 | 2023-02-16 ✅ Patent 11,931,338 granted on 2024-03-19
US20230051548A1
Human necessities

Nitrilated psilocybin derivatives and methods of using

 #23 | 2023-02-09 ✅ Patent 11,845,727 granted on 2023-12-19
US20230044216A1
Chemistry; metallurgy

Aldehyde and ketone derivatives of psilocybin and methods of using

 #24 | 2023-02-09 ✅ Patent 11,752,130 granted on 2023-09-12
US20230044066A1
Human necessities

Carboxylated psilocybin derivatives and methods of using

 #25 | 2023-02-09 ✅ Patent 12,187,679 granted on 2025-01-07
US20230043896A1
Chemistry; metallurgy

Hydroxylated psilocybin derivatives and methods of using

Also check out Enveric Biosciences Canada Inc.'s (Calgary, Canada) applicant profile with 39 patent applications submitted.

AssigneeID:

349002 ⎘